Biomedical Engineering Reference
In-Depth Information
30. Fraenkel DJ, Bardin PG, Sanderson G, Dorward M, Lau C, Johnston SL,
Holgate ST. Lower airways inflammation during rhinovirus colds in normal
and in asthmatic subjects. Am J Respir Crit Care Med 1995; 151:879-886.
31. Grunberg K, Smits HH, Timmers MC, et al. Experimental rhinovirus 16 infec-
tion: effects on cell differentials and soluble markers in sputum of asthmatic
subjects. Am J Respir Crit Care Med 1997; 156:609-616.
32. Fleming HE, Little EF, Schnurr D, et al. Rhinovirus-16 colds in healthy and
asthmatic subjects. Am J Respir Crit Care Med 1999; 160:100-108.
33. Rahman I, Skwarska E, MacNee W. Attenuation of oxidant
=
antioxidant
imbalance during treatment of exacerbations of chronic obstructive pulmonary
disease. Thorax 1997; 52:565-568.
34. Biagioli MC, Kaul P, Singh I, Turner RB. The role of oxidative stress in rhino-
virus induced elaboration of IL-8 by respiratory epithelial cells. Free Radical
Biol Med 1999; 26:454-462.
35. Turner RB, et al. Association between nasal secretion interleukin-8 concentra-
tion and symptom severity experimental rhinovirus colds. Clin Infect Dis 1998;
26:840-846.
36. Choi AMK, Knobil K, Otterbein SL, Eastman DA, Jacoby DB. Oxidant stress
responses in influenza virus pneumonia: gene expression and transcription
factor activation. Am J Physiol 1996; 271:L383-L391.
37. Carr MJ, Spalding LJ, Goldie RG, et al. Distribution of immunoreactive
endothelin in the lungs of mice during respiratory viral infection. Eur Resp J
1998; 11:79-85.
38. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bron-
chitis and the risk of coronary disease. Lancet 1996; 348:567-572.
39. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic
activity, clotting factors and long-term incidence of ischaemic heart disease in
the Northwick Park Heart Study. Lancet 1993; 324:1076-1079.
40. Wedzicha JA, Seemungal TAR, MacCallum PK, et al. Acute exacerbations of
chronic obstructive pulmonary disease are accompanied by elevations of
plasma fibrinogen and serum IL-6 levels. Thromb Haemostasis 2000; 84:
210-215.
41. Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratory tract
infections and risk of first-time acute myocardial
infarction. Lancet 1998;
351:1467-1471.
42. Zalacain R, Sobradillo V, Amilibia J, et al. Predisposing factors to bacterial
colonization in chronic obstructive pulmonary disease. Eur Resp J 1999;
13:343-348.
43. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. Airway inflamma-
tion and bronchial microbial patterns in patients with stable chronic obstructive
pulmonary disease. Eur Resp J 1999; 14:1015-1022.
44. Monso E, Rosell A, Bonet G, et al. Risk factors for lower airway bacterial colo-
nization in chronic bronchitis. Eur Resp J 1999; 13:338-342.
45. Patel IS, Seemungal TAR, Wilks M, Lloyd Owen S, Donaldson GC, Wedzicha
JA. Relationship between bacterial colonisation and the frequency, character
and severity of COPD exacerbations. Thorax, 2002; 57:759-764.
